#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11914	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2243	529.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1806	1806	T	662	T	597	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11914	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2243	529.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1540	1540	C	710	C	667	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22318	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3686	604.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1711	1711	A	724	A,G	673,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22318	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3686	604.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2345	2345	C	762	C,G	693,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22318	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3686	604.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2419	2419	A	701	A	660	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22318	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3686	604.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2971	2971	C	718	C	665	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	59798	blaTEM	861	861	100.0	blaTEM.l6.c4.ctg.1	1640	3633.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_L_00516	folP.WHO_L_00516	1	1	539	1742	folP	855	855	99.88	folP.l15.c4.ctg.1	1472	117.9	1	SNP	p	R229S	1	R229S	NONSYN	685	687	CGC	959	961	AGC	182;182;183	A;G;C	169;170;169	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	4564	gyrA	2751	2751	99.96	gyrA.l15.c30.ctg.1	3498	130.1	0	.	p	.	0	D95A	NONSYN	283	285	GAC	618	620	GCC	155;157;158	G;C;C	145;146;146	.	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	4564	gyrA	2751	2751	99.96	gyrA.l15.c30.ctg.1	3498	130.1	1	SNP	p	S91F	1	.	.	271	273	TTC	606	608	TTC	167;165;163	T;T;C	154;154;154	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	531	1246	mtrR	633	633	99.06	mtrR.l15.c17.ctg.1	1300	95.3	0	.	p	.	0	A39T	NONSYN	115	117	GCC	450	452	ACC	147;148;147	A;C;C	136;136;139	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	531	1246	mtrR	633	633	99.06	mtrR.l15.c17.ctg.1	1300	95.3	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	648	650	CAC	156;155;155	C;A;C,A	146;142;144,1	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	531	1246	mtrR	633	633	99.06	mtrR.l15.c17.ctg.1	1300	95.3	0	.	p	.	0	A127fs	FSHIFT	379	379	G	714	714	G	147	G	139	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	531	1246	mtrR	633	633	99.06	mtrR.l15.c17.ctg.1	1300	95.3	1	SNP	p	G45D	0	.	.	133	135	GGC	468	470	GGC	156;159;157	G;G;C,T	144;145;142,1	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	654	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1038	62.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3952	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2881	136.4	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1512	1514	GTC	169;168;168	G,A;T;C	148,2;149;153	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3952	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2881	136.4	1	SNP	p	D86N	0	.	.	256	258	GAC	618	620	GAC	152;151;152	G;A;C	142;140;143	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3952	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2881	136.4	1	SNP	p	S87R	1	.	.	259	261	CGT	621	623	CGT	153;153;154	C,A;G;T	142,1;145;144	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3952	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2881	136.4	1	SNP	p	R87W	0	.	.	259	261	CGT	621	623	CGT	153;153;154	C,A;G;T	142,1;145;144	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3952	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2881	136.4	1	SNP	p	R87I	0	.	.	259	261	CGT	621	623	CGT	153;153;154	C,A;G;T	142,1;145;144	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	3952	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2881	136.4	1	SNP	p	S88P	0	.	.	262	264	TCC	624	626	TCC	153;153;156	T;C;C	142;142;147	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3796	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2590	145.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1537	1539	GGC	162;163;163	G;G;C	152;153;152	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	3374	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2407	139.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1250	1252	GCA	203;203;203	G;C;A	189;184;188	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3374	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2407	139.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1253	1255	ATC	208;208;211	A;T;C	191;191;192	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3374	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2407	139.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1265	1267	GTG	218;216;217	G;T;G	199;195;196	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3374	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2407	139.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1265	1267	GTG	218;216;217	G;T;G	199;195;196	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3374	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2407	139.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1769	1771	ACC	156;156;157	A;C;C	142;144;146	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3374	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2407	139.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1823	1825	GCG	165;166;166	G;C;G	145;136;144	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3374	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2407	139.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1823	1825	GCG	165;166;166	G;C;G	145;136;144	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3374	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2407	139.6	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1946	1948	GGT	144;146;146	G;G;T	135;137;136	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3374	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2407	139.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1955	1957	GGC	145;143;140	G;G;C	134;131;128	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3374	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2407	139.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1973	1975	CCG	122;122;121	C,CG;CG,CGG;G	77,1;71,1;78	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4918	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3013	162.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1577	1579	CCG	179;179;172	C;C;G	155;160;152	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2026	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1766	114.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	607	607	C	124	C	113	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2322	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1490	154.1	0	.	p	.	0	R143G	NONSYN	427	429	AGA	739	741	GGA	156;154;153	G;G;A	141;142;139	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2322	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1490	154.1	0	.	p	.	0	.	INDELS	629	630	AA	942	944	TAG	190;190;188	T;A;G	177;179;177	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2322	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1490	154.1	0	.	p	.	0	.	MULTIPLE	631	633	TAC	946	949	CAAT	185;188;188;188	C;A;A;T	174;179;180;180	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2322	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1490	154.1	0	.	p	.	0	N212fs	FSHIFT	634	634	A	951	951	T	186	T	177	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2322	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1490	154.1	1	SNP	p	G120K	0	.	.	358	360	GGT	670	672	GGT	189;187;187	G;G;T	175;171;171	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2322	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1490	154.1	1	SNP	p	A121D	0	.	.	361	363	GCC	673	675	GCC	189;188;189	G;C;C	169;170;171	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2322	porB1b	1035	1035	98.94	porB1b.l15.c17.ctg.1	1490	154.1	1	SNP	p	A121N	0	.	.	361	363	GCC	673	675	GCC	189;188;189	G;C;C	169;170;171	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	8998	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4814	186.3	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2033	2035	AAT	211;212;210	A;A;T	199;197;199	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	960	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1060	89.9	1	SNP	p	V57M	1	.	.	169	171	ATG	461	463	ATG	204;203;204	A;T;G	190;190;190	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2549	380.8	0	.	p	.	0	M177T	NONSYN	529	531	ATG	931	933	ACG	383;384;383	A;C,T;G	364;367,1;366	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2549	380.8	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	952	954	GAC	343;341;342	G;A;C	339;338;338	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2549	380.8	0	.	p	.	0	T190M	NONSYN	568	570	ACG	970	972	ATG	326;325;320	A;T;G	325;323;317	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2549	380.8	0	.	p	.	0	L194S	NONSYN	580	582	TTA	982	984	TCA	308;310;306	T;C;A,T	306;307;303,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2549	380.8	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	1027	1029	CAG	310;313;315	C;A;G	305;308;311	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2549	380.8	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1048	1050	CTT	297;292;289	C;T;T	291;287;285	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2549	380.8	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1069	1071	AGT	321;322;328	A;G;T	312;312;315	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2549	380.8	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1138	1140	CCG	485;488;488	C;C;G	444;447;446	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2549	380.8	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1240	1242	TCG	498;496;498	T;C;G	464;464;467	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2549	380.8	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1411	1413	AAA	288;281;276	A;A;A	274;267;264	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2549	380.8	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1414	1416	AAG	279;277;279	A;A;G	267;265;266	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2549	380.8	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1429	1431	CAC	248;247;250	C;A;C	245;233;246	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2549	380.8	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1468	1470	GAA	223;220;216	G;A;A	220;219;214	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2549	380.8	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1546	1548	ACG	143;145;148	A;C;G,T	143;144;147,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2549	380.8	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1597	1599	ATT	225;226;224	A;T;T	214;213;212	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2549	380.8	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1600	1602	AGT	224;221;219	A;G;T	211;208;203	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2549	380.8	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1639	1641	CTA	243;244;249	C;T;A	219;220;224	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2549	380.8	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1681	1683	AAT	180;183;186	A;A;T	176;178;181	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2549	380.8	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1750	1752	TCA	243;244;246	T;C;A	235;234;237	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2549	380.8	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1774	1776	ATG	272;271;273	A;T;G	260;258;258	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2549	380.8	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2068	2070	ACC	586;590;590	A;C,A;C	550;553,1;554	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9740	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2549	380.8	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2164	2166	GAA	524;521;522	G;A;A	496;498;498	.	Tetracycline resistance
